Catalytica, Inc. develops proprietary catalytic technologies to yield economic and environmental benefits by lowering manufacturing costs and reducing hazardous byproducts. The company currently focuses on production of pharmaceutical components and development of advanced combustion systems to reduce toxic emissions generated by natural gas turbines. The products are used in eliminating environmental pollutants and production of pharmaceuticals. The company has spent $7 million till date towards Year 2000 expenses. During 1999 the company acquired Wyckoff Chemical company, Inc. Fine chemical products accounted for 94% of 1999 revenues and research and development contracts, 6%.